1. Jehovah’s Witness Patients: Interventions for Successful Stem Cell Transplantation Without Blood Product Transfusions for Hematologic Malignancies
- Author
-
Sandra Rome, Amanda D. Park, and Raymond Gantioque
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Population ,Context (language use) ,03 medical and health sciences ,0302 clinical medicine ,Blood product ,medicine ,Humans ,Intensive care medicine ,education ,Jehovah's Witnesses ,General Environmental Science ,Chemotherapy ,education.field_of_study ,030504 nursing ,business.industry ,Religion and Medicine ,Hematopoietic Stem Cell Transplantation ,Witness ,humanities ,Transplantation ,Haematopoiesis ,Hematologic Neoplasms ,030220 oncology & carcinogenesis ,General Earth and Planetary Sciences ,Stem cell ,0305 other medical science ,business - Abstract
Background Jehovah's Witnesses are members of a religion that prohibits them from accepting blood product transfusions. This refusal makes them a particularly compelling population in the context of hematologic malignancies and stem cell transplantation, because blood product transfusions are a mainstay of supportive treatment. Objectives This article presents preventive and supportive measures allowing Jehovah's Witness patients the opportunity to receive a stem cell transplantation without blood product transfusions. Methods A literature review was done that included evidence focusing on optimizing hematopoiesis, blood loss prevention, alterations in chemotherapy regimens, and implications for nursing practice. Findings With proper preventive and supportive care measures, Jehovah's Witness patients can receive stem cell transplantations for hematologic malignancies without blood product transfusions.
- Published
- 2019
- Full Text
- View/download PDF